Skip to main content

Table 2 Type of drugs used

From: Hypertension control and care at Mulago Hospital ambulatory clinic, Kampala-Uganda

 

n (%)

One drug (5.8% n = 43)

 ARBs/ACEi

10 (23.3)

 Calcium channel blocker

10 (23.3)

 Diuretics

5 (11.6)

 Beta blocker

15 (34.9)

 Centrally acting vasodilator

1 (2.3)

 Potassium sparing diuretic

2 (4.6)

Two drugs (32.8% n = 243)

 ARBs/ACEi and beta blocker

33 (13.6)

 ARBs/ACEi and calcium channel blocker

66 (27.2)

 ARBs/ACEi and thiazide diuretic

37 (15.2)

 Beta blocker and calcium channel blocker

16 (6.6)

 Beta blocker and thiazide diuretic

37 (15.2)

 Others

6 (2.5)

Three drugs (42.2% n = 313)

 ARBs/ACEi, beta blocker and calcium channel blocker

53 (16.9)

 ARBs/ACEi, beta blocker and thiazide diuretic

42 (13.4)

 ARBs/ACEi calcium channel blocker and thiazide diuretic

149 (47.6)

 Beta blocker, calcium channel blocker and thiazide diuretic

55 (17.6)

 Others

14 (4.5)

Four drugs (16.5 n = 122)

 ARBs/ACEi, beta blocker, calcium channel blocker and thiazide diuretic

102 (83.6)

 ARBs/ACEi, calcium channel blocker thiazide diuretic and centrally acting vasodilator

6 (4.9)

 Others

14 (11.5)

Five drugs (1.9% n = 14)

 ARBs/ACEi, beta blocker, calcium channel blocker,  thiazide diuretic and centrally acting vasodilator

5 (35.7)

 ARBs/ACEi, beta blocker, calcium channel blocker, thiazide diuretic and potassium sparing diuretic

8 (57.1)

 ARBs/ACEi, beta blocker, calcium channel blocker, centrally acting vasodilator and potassium sparing diuretic

1 (7.1)

  1. ARBs angiotensin receptor blockers, ACEi angiotensin converting enzyme inhibitor